Advertisement

Preneoplastic Lesions In Kidney And Carcinogenesis By Non-Genotoxic Compounds

  • D. R. Dietrich
  • T. Rasonyi
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 17)

Abstract

Carcinogenesis is known to be a multistep process which involves two or more genetic events and requires cell proliferation (Pitot 1986; Barrett and Wiseman 1987; Farber and Sarma 1987; Knudson 1987; Cerutti 1988; Lutz 1990). The genetic events can result from point mutations, chromosomal rearrangements (Croce and Klein 1990), insertions or deletions of genes, and gene amplification. Cell replication is required to convert DNA damage to mutations, irrespective of whether this damage is occurring spontaneously or induced by DNA damaging (genotoxic) compounds. Spontaneous mutations are assumed to stem from spontaneous genetic events such as depurination and deamination of DNA, formation of covalent DNA adducts by physiological reactive cellular constituents, DNA damage by oxygen free radicals produced in cellular metabolism, errors in DNA replication (Loeb 1989). Normally the cell has the possibility to either repair the damaged DNA, or, if the damage is irrepairable, to destroy itself via tumor suppressor gene product (e.g. p53) mediated apoptosis (Lane 1993). Abrogated DNA repair or apoptosis of damaged cells in conjunction with a cell proliferative stimulus can lead to the formation of clusters of mutated cells and clonal expansion. Continued enhanced proliferation and expansion of such clones increases the probability of additional genetic events within these populations (Knudson 1987) thus providing a basis for the formation of preneoplastic lesions and progression to veritable tumors (Swenberg et al. 1987; Dietrich and Swenberg 1991b). Although the sequence of events described above appears reasonable, little direct evidence has been put forward so far. However, some corroboration is provided by the observation that control animals from strains of laboratory rodents present with an appreciable incidence of spontaneous preneoplastic lesions and tumors (Dietrich and Swenberg 1991b). The incidence of spontaneous tumors varies greatly from tissue to tissue, strain to strain, sex to sex, and species to species (Swenberg and Short 1987).

Keywords

Renal Tumor Atypical Hyperplasia Preneoplastic Lesion Clear Cell Tumor Unleaded Gasoline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alden CL, Kanerva RL (1982) Reversibility of renal cortical lesions induced in rats by high doses of nitrilotriacetate in chronic feeding studies. Fd Chem Tox 20:935–937CrossRefGoogle Scholar
  2. Alden CL, Kanerva RL, Anderson RL, Adkins AG (1981) Short-term effects of dietary nitrilotriacetic acid in the male Charles River rat kidney. Vet Path 18: 549–559Google Scholar
  3. Anderson RL (1981) The role of zinc in nitrilotriacetate (NTA) associated renal tubular cell toxicity. Fd Cosmet Toxicol 19:639–650CrossRefGoogle Scholar
  4. Anderson RL, Bishop WE, Campbell RL (1985) A review of the environmental and mammalian toxicology of nitrilotriacetic acid. CRC Crit Rev Toxicol 15(1): 1–102CrossRefGoogle Scholar
  5. Bannasch P, Zerban H (1990) Animal models and renal carcinogenesis. In: Eble JN (ed) Contemporary issues of surgical pathology. New York, Churchill Livingstone, pp 1–34Google Scholar
  6. Barrett JC, Wiseman RW (1987) Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogenic risk assessment. Environ Health Persp 76:65–70CrossRefGoogle Scholar
  7. Boorman G. (1989) Toxicology and carcinogenesis studies of ochratoxin A in F344/N rats. National Toxicology Program, Technical Report Series No. 358Google Scholar
  8. Borghoff SJ, Short BG, Swenberg JA (1990) Biochemical mechanisms and pathobiology of alpha 2u-globulin nephropathy. Annu Rev Pharmacol Toxicol 30:349–67PubMedCrossRefGoogle Scholar
  9. Biisselberg D, Evans ML, Rahman H, Carpenter DO (1990) Zn2+ blocks the voltage activated calcium current of Aplysia neurons. Neuroscience Lett 117:117–122CrossRefGoogle Scholar
  10. Cerutti PA (1988) Commentary. Response modification creates promotability in multistage carcinogenesis. Carcinogenesis 9:519–526PubMedCrossRefGoogle Scholar
  11. Croce CM, Klein G (1990) Chromosomal-translocation and cancer. In: Schirrmacher V (ed) Cancer-Tumors, Cells, Genes. Heidelberg, Scientific American pp 102–109Google Scholar
  12. Dietrich DR (1994) Alpha 2i-Globulin: Species and sex specific protein synthesis and excretion and its association with chemically induced renal toxicity and neoplasia in the male rat, and its relevance in conjunction with human cancer risk assessment Rev Biochem Toxicol 13:in pressGoogle Scholar
  13. Dietrich DR, Swenberg JA (1991a) NCI-Black-Reiter (NBR) male rats fail to develop renal disease following exposure to agents that induce alpha-2u-globulin (alpha 2u) nephropathy. Fundam Appl Toxicol 16(4):749–62PubMedCrossRefGoogle Scholar
  14. Dietrich DR, Swenberg J A (1991b) Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mut Res 248: 239–260CrossRefGoogle Scholar
  15. Dietrich DR, Swenberg JA (1991c) The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res 51(13):3512–3521PubMedGoogle Scholar
  16. Dietrich DR, Swenberg JA (1993) Renal carcinogenesis. In: Hook JB, Goldstein RS (eds) Toxicology of the Kidney. New York, Raven Press pp 495–537Google Scholar
  17. Dirheimer G, Creppy EE (1991) Mechanism of action of ochratoxin A. In: Castergnaro M, Plestina R, Dirheimer G, Chernozemsky IM, Bartsch H (eds) Mycotoxins, Endemic Nephropathy and Urinary tract tumors. Lyon, International Agency for Research on Cancer, IARC. pp 171–186Google Scholar
  18. Farber E, Sarma DRS (1987) Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 56:4–22PubMedGoogle Scholar
  19. Knudson AGJr (1987) A two-mutational model for human cancer. In: Klein G (ed) Advances in Viral Oncology. New York, Raven Press 1–17Google Scholar
  20. Lane DP (1993) A death in the life of p53. Nature 362:786–787PubMedCrossRefGoogle Scholar
  21. LeBoeuf RA, Kerckaert GA, Aardema MJ, Pdiley JA, Raineri R (1990) Enhanced morphological and neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.70. In: Mendelsohn ML, Albertini RJ (eds) Mutation and the Environment: Part D: Carcinogenesis. New York, Wiley-Lyss pp 219–228Google Scholar
  22. Loeb LA (1989) Endogenous carcinogenesis: molecular oncology into the twenty-first century — Presidential Address. Cancer Res 49:5489–5496PubMedGoogle Scholar
  23. Lutz WK (1986) Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. J Cancer Res Clin Oncol 112:85–91PubMedCrossRefGoogle Scholar
  24. Lutz WK (1990) Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mut Res 238:287–295Google Scholar
  25. Martin SJ, Cotter TG (1994) Apoptosis of human leukemia: Induction, morphology, and molecular mechanisms. In: Tomei LD, Cope FO (eds) Apoptosis II: The molecular basis of apoptosis in disease. Cold Spring Harbor, Cold Spring Harbor Press pp 185–229Google Scholar
  26. Martin SJ, Green DR, Cotter TG (1994) Dicing with death: dissecting the components of the apoptosis machinery. Trends in Biol Sei 19:26–30CrossRefGoogle Scholar
  27. Mills JW, Zhou J-H, Cardoza L, Ferm VH (1992) Zinc alters actin filaments in Madin-Darby canine kidney cells. Toxicol Appl Pharmacol 116:92–100PubMedCrossRefGoogle Scholar
  28. Peitsch MC, Mannherz HG, Tschopp J (1994) The apoptosis endonucleases: cleaning up after cell death. Trends in Cell Biol 4:37–41CrossRefGoogle Scholar
  29. Pfohl-Leszcowicz A, Chakor K, Creppy EE, Dirheimer G (1991). DNA adduet formation in mice treated with ochratoxin A. In: Castergnaro M, Plestina R, Dirheimer G, Chemozemsky IM, Bartsch H (eds) Mycotoxins, Endemie Nephropathy and Urinaiy tract tumors. Lyon, International Agency for Research on Cancer, IARC pp 245–253Google Scholar
  30. Pitot HC (1986) The natural history of neoplastic development: Initiation and Promotion. In: Pitot HC (ed) Fundamentals of Oncology. New York, Marcel Dekker IncGoogle Scholar
  31. Rahimtula AD, Chong X (1991) Alterations in calcium homeostasis as a possible cause of ochratoxin A nephrotoxicity. In: Castergnaro M, Plestina R, Dirheimer G, Chemozemsky IM, Bartsch H (eds) Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Lyon, International Agency for Research on Cancer, IARC pp 207–214Google Scholar
  32. Rasonyi T, Dietrich DR, Schlatter J, Schlatter C (1995) Site specific toxicity and regenerative cell proliferation in male and female F344 rats treated for 4 weeks with different doses of ochratoxin A. Fundam Appl Toxicol; in preparationGoogle Scholar
  33. Rivera Torres MI, Caudill D, Lehman-McKeeman LD (1989) Lysosomal degradation of alpha2u-globulin (A2u): Role of cysteine and aspartic acid proteinases and effects of d-limonene binding. Toxicologist 9(1):314Google Scholar
  34. Short BG, Burnett VL, Swenberg JA (1989) Elevated proliferation of proximal tubule cells and localization of accumulated alpha 2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane. Toxicol Appl Pharmacol 101(3):414–31PubMedCrossRefGoogle Scholar
  35. Short BG, Steinhagen WH, Swenberg JA (1989) Promoting effects of unleaded gasoline and 2,2,4-trimethylpentane on the development of atypical cell foci and renal tubular cell tumors in rats exposed to N-ethyl-N-hydroxyethylnitrosamine. Cancer Res 49(22):6369–6378PubMedGoogle Scholar
  36. Stevens JL, Jones TW (1990) The role of damage and proliferation in renal carcinogenesis. Toxicol Lett 53:121–126PubMedCrossRefGoogle Scholar
  37. Stoerkel S (1993) Carcinomas and oncocytomas of the kidney. In: Denk H, Dietel M, Fischer R, Hoefler H, Katenkamp D, Seifert G, Dhom G, Eder M, Heitz PU, Holzner H, Lennert K, Thoenes W (eds) Progress in Pathology. New York, Gustav Fischer Verlag pp 164Google Scholar
  38. Swenberg JA, Richardson FC, Boucheron JA, Deal FH, Belinsky SA, Charbonneau M, Short BG (1987) High-to low-dose extrapolation: Critical determinants involved in the dose response of carcinogenic substances. Environ Health Persp 76:57–63CrossRefGoogle Scholar
  39. Swenberg JA, Short BG (1987) Influence of cytotoxicity on the induction of tumors. In: Butterworth BE, Slag a TJ (eds) Nongenotoxic mechanisms in carcinogenesis. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory pp 151–161Google Scholar
  40. Thoenes W, Stoerkel S (1991) Die Pathologie der benignen und malignen Nierenzelltumoren. Urologe-A 30:W41-W50PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • D. R. Dietrich
    • 1
  • T. Rasonyi
    • 1
  1. 1.Institute of Toxicology, Swiss Federal Institute of TechnologyUniversity of ZurichSchwerzenbachSwitzerland

Personalised recommendations